Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

The gel effectively thickens eyelashes and eyebrows without side effects.

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Different ethnic hair traits must be considered for successful hair restoration surgery to achieve natural-looking results.

Acitretin can cause eyebrow and eyelash hair loss.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Nanofat grafting is better for delicate areas and combining it with lipofilling might improve hair loss treatment.

Hair restoration for East Asians should consider their unique characteristics like head shape, hair thickness, and hair density, and use modified procedures and treatments to minimize scarring and maintain hair density.

The elderly woman experienced hair loss and scalp itching, especially at the front hairline, and lost her eyebrows.

Gefitinib can cause hair and eyebrow darkening.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Early diagnosis of Keratosis pilaris atrophicans faciei can lead to better, personalized treatments.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Alopecia areata negatively impacts quality of life and work, even with moderate hair loss.

Thioglycolate compounds in brow lamination can cause skin irritation and other health issues.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.